387 is too far away. Besides I do not listen to any analysts. We will worry about it if and when it moves at that far up.
Sentiment: Strong Buy
Biogen's drug sucks. Anavex's is the real deal. Haven't heard of the name? You will.
Is their drug even much better than donepezil? Its another one of the immunoglobulin drugs that are underwhelming. Anavex's drugs 2-73 and 3-71 have better results and unlike Biogen's drug, have no side effects. They are gonna blow that Biogen drug outta the water.
Gotta get past this Friday's jobs report, then BIIB shareholder's meeting slated for next wedn. June 8, then we'll see. Very possible if everything pans out okay.
Cody : Great call ! RNN, is my portfolio. This company has a ton of potential.Bought more today, and will continue to accumulate more RNN.